DrugPatentWatch Database Preview

Binimetinib - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for binimetinib and what is the scope of binimetinib patent protection?

Binimetinib is the generic ingredient in one branded drug marketed by Array Biopharma Inc and is included in one NDA. There are eleven patents protecting this compound. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Summary for binimetinib

US Patents:	11
Tradenames:	1
Applicants:	1
NDAs:	1
Suppliers / Packagers:	1
Bulk Api Vendors:	56
Clinical Trials:	20
Patent Applications:	142
DailyMed Link:	binimetinib at DailyMed

Synonyms for binimetinib

1073666-70-2

1201685-05-3

1417448-81-7

181R97MR71

5-((4-bromo-2-fluorophenyl)amino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzo[d]imidazole-6-carboxamide

5-[(4-Bromo-2-Fluorophenyl)Amino]-4-Fluoro-N-(2-Hydroxyethoxy)-1-Methyl-1H-Benzimidazole-6-Carboxami

5-[(4-Bromo-2-fluorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide

6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethyoxy)-amide

6-(4-bromo-2-fluorophenylamino)-7-fluoro-N-(2-hydroxyethoxy)-3-methyl-3H-benzo[d]imidazole-5-carboxamide

6-[(4-bromo-2-fluorophenyl)amino]-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide

606143-89-9

AB0095018

AC-29023

ACWZRVQXLIRSDF-UHFFFAOYSA-N

AKOS026750517

AOB2072

ARRY 162

ARRY-162

ARRY-162,MEK-162

ARRY-162; ARRY-438162; MEK 162; ARRY 162; ARRY 438162

ARRY-438162

AS-16706

BC600594

Binimetinib (JAN/USAN)

Binimetinib (MEK162, ARRY-162, ARRY-438162)

Binimetinib [USAN:INN]

Binimetinib;MEK-162; ARRY-162;ARRY-438162

C17H15BrF2N4O3

cas:606143-89-9;MEK162

CHEMBL3187723

CS-0627

D0C4LF

D10604

DB11967

DTXSID70209422

EX-A1024

FT-0697088

GTPL7921

HMS3652J14

HY-15202

J-516581

KB-124302

KB-78305

KS-0000062X

MEK-162

MEK162

MEK162 (ARRY-162, ARRY-438162)

MEK162 (Arry-162)

MEK162(Binimetinib)

MLS006011180

MolPort-028-720-357

NCGC00345804-01

NVP-MEK162

QCR-138

RL04283

s7007

SCHEMBL570088

SMR004702949

UNII-181R97MR71

W-5894

Y1468

ZINC38460704

US Patents and Regulatory Information for binimetinib

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Array Biopharma Inc	MEKTOVI	binimetinib	TABLET;ORAL	210498-001	Jun 27, 2018		RX	Yes	Yes
Array Biopharma Inc	MEKTOVI	binimetinib	TABLET;ORAL	210498-001	Jun 27, 2018		RX	Yes	Yes
Array Biopharma Inc	MEKTOVI	binimetinib	TABLET;ORAL	210498-001	Jun 27, 2018		RX	Yes	Yes			Y	Y
Array Biopharma Inc	MEKTOVI	binimetinib	TABLET;ORAL	210498-001	Jun 27, 2018		RX	Yes	Yes
Array Biopharma Inc	MEKTOVI	binimetinib	TABLET;ORAL	210498-001	Jun 27, 2018		RX	Yes	Yes
Array Biopharma Inc	MEKTOVI	binimetinib	TABLET;ORAL	210498-001	Jun 27, 2018		RX	Yes	Yes			Y	Y

International Patents for binimetinib

Country	Document Number	Estimated Expiration
Eurasian Patent Organization	201200373
South Korea	20060121853
China	101486682
Russian Federation	2004127926
Portugal	2130537
Germany	60330227